Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Return on Equity (2020 - 2025)

Celularity (CELU) has disclosed Return on Equity for 6 consecutive years, with 3.54% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity rose 509.0% to 3.54% in Q3 2025 year-over-year; TTM through Sep 2025 was 3.54%, a 509.0% increase, with the full-year FY2024 number at 2.33%, down 69.0% from a year prior.
  • Return on Equity was 3.54% for Q3 2025 at Celularity, down from 4.75% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 4.75% in Q2 2025 to a low of 33.4% in Q1 2025.
  • A 5-year average of 2.47% and a median of 0.6% in 2023 define the central range for Return on Equity.
  • Biggest YoY gain for Return on Equity was 857bps in 2025; the steepest drop was -2913bps in 2025.
  • Celularity's Return on Equity stood at 1.02% in 2021, then skyrocketed by 108bps to 0.08% in 2022, then plummeted by -7154bps to 5.51% in 2023, then rose by 20bps to 4.43% in 2024, then surged by 180bps to 3.54% in 2025.
  • Per Business Quant, the three most recent readings for CELU's Return on Equity are 3.54% (Q3 2025), 4.75% (Q2 2025), and 33.4% (Q1 2025).